Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ROKA
3251
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $51K | ﹤0.01% |
7,330
+1,790
| +32% | +$14.8K |
2015 Q4
3 quarters
|
|
|
WGA
3252
DELISTED
AG&E Holdings Inc
WGA
| $51K | ﹤0.01% |
181,376
+35,600
| +24% | +$9.9K |
2013 Q2
13 quarters
|
|
|
STDY
3253
DELISTED
SteadyMed Ltd
STDY
| $50K | ﹤0.01% |
14,000
+3,200
| +30% | +$10.9K |
2016 Q2
1 quarter
|
|
|
GFN
3254
DELISTED
General Finance Corporation
GFN
| $50K | ﹤0.01% |
11,000
-14,900
| -58% | -$64.8K |
2015 Q1
6 quarters
|
|
|
VBIV
3255
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $49K | ﹤0.01% |
+473
| New | +$53.1K |
2016 Q3
0 quarters
|
|
3256
Siebert Financial
SIEB
$90.4M
| $48K | ﹤0.01% |
34,600
+4,900
| +16% | +$6.55K |
2013 Q2
13 quarters
|
|
|
RIBT
3257
DELISTED
RiceBran Technologies
RIBT
| $48K | ﹤0.01% |
3,560
+830
| +30% | +$12.2K |
2015 Q4
3 quarters
|
|
|
MCZ
3258
DELISTED
Mad Catz Interactive
MCZ
| $48K | ﹤0.01% |
215,300
-2,200
| -1% | -$503 |
2013 Q2
13 quarters
|
|
|
CALI
3259
DELISTED
China Auto Logistics Inc
CALI
| $46K | ﹤0.01% |
+15,700
| New | +$41.3K |
2016 Q3
0 quarters
|
|
|
GMO
3260
DELISTED
General Moly, Inc.
GMO
| $45K | ﹤0.01% |
161,109
+367
| +0.2% | +$117 |
2015 Q4
3 quarters
|
|
|
CREG
3261
DELISTED
Smart Powerr
CREG
| $44K | ﹤0.01% |
+24
| New | +$47K |
2016 Q3
0 quarters
|
|
|
VMEM
3262
DELISTED
VIOLIN MEMORY, INC.
VMEM
| $44K | ﹤0.01% |
+60,073
| New | +$119K |
2016 Q3
0 quarters
|
|
|
IMNP
3263
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $43K | ﹤0.01% |
+7,625
| New | +$56.3K |
2016 Q3
0 quarters
|
|
3264
XTI Aerospace
XTIA
$31.2M
| – | – |
0
| – | – |
2015 Q4
3 quarters
|
|
|
UDF
3265
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
| $42K | ﹤0.01% |
129,700
| – | – |
2015 Q1
6 quarters
|
|
3266
Milestone Scientific
MLSS
$32.9M
| $40K | ﹤0.01% |
+18,500
| New | +$46.5K |
2016 Q3
0 quarters
|
|
3267
United States Antimony
UAMY
$555M
| $40K | ﹤0.01% |
+89,200
| New | +$32.4K |
2016 Q3
0 quarters
|
|
|
ECT
3268
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $40K | ﹤0.01% |
+18,178
| New | +$38.7K |
2016 Q3
0 quarters
|
|
3269
Atlanticus Holdings
ATLC
$1.39B
| $39K | ﹤0.01% |
12,900
+1,800
| +16% | +$5.32K |
2015 Q4
3 quarters
|
|
|
SSKN
3270
DELISTED
Strata Skin Sciences
SSKN
| $39K | ﹤0.01% |
1,454
+572
| +65% | +$18.2K |
2016 Q1
2 quarters
|
|
|
FCSC
3271
DELISTED
Fibrocell Science Inc.
FCSC
| $38K | ﹤0.01% |
+3,473
| New | +$51.5K |
2016 Q3
0 quarters
|
|
|
WRN
3272
Western Copper and Gold
WRN
$475M
| $35K | ﹤0.01% |
41,900
+22,500
| +116% | +$19.1K |
2016 Q2
1 quarter
|
|
|
DGSE
3273
DELISTED
DGSE Companies, Inc.
DGSE
| $35K | ﹤0.01% |
41,500
+7,900
| +24% | +$6.48K |
2014 Q2
9 quarters
|
|
3274
Comstock Holding Companies
CHCI
$201M
| $33K | ﹤0.01% |
+17,784
| New | +$33K |
2016 Q3
0 quarters
|
|
3275
Digital Turbine
APPS
$1.3B
| $32K | ﹤0.01% |
+30,274
| New | +$35.1K |
2016 Q3
0 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.